They wouldn't get the company for that because we wouldn't allow it. The company also has 2 paths to funding, they may not even end up partnering with pharma.
Ann: Positive AD-214 Phase I extension study results, page-189
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $11.51M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $10.44K | 549.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 561999 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 631544 | 3 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |